||Publications (since 2009):
Verma N, Chaudhary UB, Costa LJ, Gudena V, Lazarchick J. Primary testicular lymphoma and AIDS. Ann Clin Lab Sci. 2010 Winter;40(1):75-9. PubMed PMID:20124334.
Chaudhary UB, Turner JS. Finasteride. Expert Opin Drug Metab Toxicol. 2010
Jul;6(7):873-81. doi: 10.1517/17425255.2010.495944. Review. PubMed PMID:
Saddoughi SA, Garrett-Mayer E, Chaudhary U, O'Brien PE, Afrin LB, Day TA,Gillespie MB, Sharma AK, Wilhoit CS, Bostick R, Senkal CE, Hannun YA, Bielawski J, Simon GR, Shirai K, Ogretmen B. Results of a phase II trial of gemcitabine plus doxorubicin in patients with recurrent head and neck cancers: serum C₁₈-ceramide as a novel biomarker for monitoring response. Clin Cancer Res. 2011 Sep 15;17(18):6097-105. doi: 10.1158/1078-0432.CCR-11-0930. Epub 2011 Jul 26. PubMed PMID: 21791630; PubMed Central PMCID: PMC3176980.
Chaudhary UB, Verma N, Keane T, Gudena V. A phase II study of gemcitabine and irinotecan in patients with locally advanced or metastatic bladder cancer. Am J Clin Oncol. 2014 Apr;37(2):188-93. doi: 0.1097/COC.0b013e318271b306. PubMed PMID: 23241501.
Neurologic Manifestation of Colonic Adenocarcinoma. Terence T. Sio, Mersedes PAredes, Uzair Chaudhary. Rare Tumors 2012: Volume 4:e32
Rashid MH, Hadziahmetovic M, Chaudhary UB. Durable, complete remission with bevacizumab-based chemotherapy in a patient with metastatic gastroesophageal junction cancer. Gastrointest Cancer Res. 2012 Sep;5(5):177-8. PubMed PMID: 23112887; PubMed Central PMCID: PMC3481151.
Marshall DT, Ramey S, Golshayan AR, Keane TE, Kraft AS, Chaudhary U. Phase I trial of weekly docetaxel, total androgen blockade, and image-guided
intensity-modulated radiotherapy for localized high-risk prostate adenocarcinoma. Clin Genitourin Cancer. 2014 Apr;12(2):80-6. doi: 10.1016/j.clgc.2013.11.019. Epub 2013 Nov 13. PubMed PMID: 24378335.
Sio TT, Ko J, Gudena VK, Verma N, Chaudhary UB. Chemotherapeutic and targeted biological agents for metastatic bladder cancer: a comprehensive review. Int J Urol. 2014 Jul;21(7):630-7. doi: 10.1111/iju.12407. Epub 2014 Jan 23. Review. PubMed PMID: 24455982.
Esnaola NF, Chaudhary UB, O'Brien P, Garrett-Mayer E, Camp ER, Thomas MB, Cole DJ, Montero AJ, Hoffman BJ, Romagnuolo J, Orwat KP, Marshall DT. Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiation in patients with borderline resectable or unresectable locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2014 Mar 15;88(4):837-44. doi: 10.1016/j.ijrobp.2013.12.030. PubMed PMID:24606850; PubMed Central PMCID: PMC4120643.
Neo-adjuvant therapies for unresectable liver metastases.Matthew Beldner, Uzair B. Chaudhary and Mohammad W. Saif. (Submitted)
The emerging role of targeted therapies in metastatic renal cell carcinoma (Invited commentary for Biochemical Pharmacology). Uzair B. Chaudhary. (In Preparation)
M-TOR inhibition for cancer (Invited commentary for Current cancer drug targets). Uzair B. Chaudhary. (In Preparation)
Book and Chapters:
Submitted Manuscript - Neo-adjuvant therapies for unresectable liver metastases.Matthew Beldner, Uzair B. Chaudhary and Mohammad W. Saif. (Submitted)
The emerging role of targeted therapies in metastatic renal cell carcinoma (Invited commentary for Biochemical Pharmacology). Uzair B. Chaudhary - Manuscripts in Preparation
M-TOR inhibition for cancer (Invited commentary for Current cancer drug targets). Uzair B. Chaudhary. - Manuscript in Preparation
Non-platinum chemotherapy for metastatic bladder cancer. Vinay Gudena, Nitin Verma and Uzair B. Chaudhary. - Manuscript in Preparation
Intermittent Androgen Deprivation (IAD) as treatment for localized and recurrent prostate cancer. Uzair B. Chaudhary, Gary D. Grossfeld, David M. Reese, Eric J. Small, and Peter R. Carroll
Intermittent Androgen Deprivation (IAD); Patterns of failure in clinically localized prostate cancer. Uzair B. Chaudhary, Gary D., David M. Reese, Eric J. Small, and Peter R. Carroll (Poster presenation at the 36th American Society of Clinical Oncology Meeting)
Long term complications of chemotherapy for germ cell tumours. U.B. Chaudhary and J.R. Haldas. Urological Surveys. The Journal of Urology: 172 (3) page1204. Editorial comment by Dr Jerome P. Richie, M.D.
Phase II trial of pegylated Interferon alpha-2b, GM-CSF, and Thalidomide in metastaticprogressive renal cell carcinoma. Am Soc Clin Oncol. (Abstract #4800) R. Sawhney, F. Brescia, T.Keane, H.Clark, U.B. Chaudhary.
Concurrent split course hyperfractionated radiotherapy (HfxRT) with biweekly cisplatin (DDP) and paclitaxel (P) with recurrent irradiated squamous cell carcinoma of the head and neck (SCCHN): The MUSC experience. R. Sawhney, A. Dragun, R.K. Stuart, U.B. Chaudhary, T.Day, M.B. Gillespie, A. Sharma.
Phase I trial of bortezomib and celecoxib in patients with advanced solid tumors S. Dunder, U. Chaudhary, M. Green, M. Meyer, F. Brescia, A. Kraft, A. Montero, S. Salzer.
Detection of circulating tumor cells in the peripheral blood of patients with Androgen-independent, Advanced or Metastatic Prostate cancer. D.T. Marshall, M.C. Mitas, U.B. Chaudhary, S. Gattoni-Celli. (Submitted to ASTRO)
Preliminary results of a phase II study of Induction Gemcitabine/Oxalipatin (GEMOX) and Cetuximab followed by surgery or concurrent Instensity Modulated Radiation Therapy (IMRT) and Capecitabine for locally advanced Pancreatic Cancer. J Brashears, AJ Brisendine, U.B Chaudhary, NF Esanola, AJ Montero and TD Marshall.(Poster presentation at ASTRO)
Phase II trial with Doxotubicin and Gemcitabine comination for the treatment of head and neck cancers: From the Sphingolipid-Signaling bench to the bedside. Uzair Chaudhary, Paul O'Brien, Larry Afrin, Keisuke Shirai, Terry A Day, Boyd Gillispie, Joshua Horning, Anand Sharma, Christina Wihoit, Sahar Saddoughi, Can E Senkal, Yusuf A. Hannun and Besim Ogretmen. (Poster presentation at the Hollings Cancer Center Retreat)
Results of a Phase II neoadjuvant tial with gemcitabine/oxaliplatin and cetuximab followed by surgery or concurrent intensity modulated radiation therapy (IMRT) with capecitabine for patients with borderline resectable and unresectable nonmetastatic pancreatic cancer. U.B. Chaudary, V. Gudina, S. Cole, P. O'Brien, A.J. Montero, D.T. Marshall, W. Amy, B. Hoffman. (Poster presentation at ASCO GI 2009)
Hepatocellular Cancer Presentation as an Intra-Cardiac Mass. Uzair B. Chaudary, Ambar Rahman, Aifra Ahmend, Pervaiz Chaudhary.(Poster persentation at the ACP 2009 Annual meeting)
Rapidly Progressive Renal Failure Presentation as Multiple Myeoma. Uzair B. Chaudhary, Ambar Rahman, Alfra Ahmed.(Poster presentation at the ACP Annual meeting)
IMRT To Reduce Toxicity In Chemoradiation For Locally Advanced Pancreatic Cancer - Preliminary Results Of A Phase II Trial. U. Chaudhary 1,2, D. T. Marshall1, P. O'Brien1, B. Hoffman1, E. Garrett-Mayer1, A. Brisendine1, B. D. Jones1, L. E. Terwilliger1, K. Cranford1, N. Esnaola
Diffuse Large B-Cell Lymphoma of the Spleen with Rib Metastasis Presenting as Recalcitrant Hypercalcemia and Elevated Vitamin D Level. Miguel Risco,M.D., Uzair B. Chaudhary, M.D., (Poster Presentation ACP Northern Residents and Students Abstract) 2015
Malignant testicular mixed germ cell tumor with melanomatous component; Artem Ryazantsev, M.D.,Risco M, Gilmore G, Chaudhary U. (Poster Presentation ACP Northern Residents and Students Abstract) 2015
Predicting metastasis in non-functioning pancreatic tumors with reappraisal of the tumor size significance: a population based analysis. Jonathan Romanyshyn MD1, Babak Eghbalieh MD1, Mehdi Barati PhD2 , Uzair Chaudhary MD1, Amir H Fathi MD1/> 1. HPB cancer program at University of San Francisco, Fresno, CA
2. University of Wisconsin, Milwaukee, Wisconsin 2/2016